Delivery Order SPE2DB22D9304-SPE2DB24FSTB5

Award Date 9/11/24
Potential Completion Date 10/2/24
Potential Value $8.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $42,918.72 firm fixed-price delivery order contract is for the supply of 4,566,006,905 units of the pharmaceutical product KCENTRA 1,000 UNIT VIALS. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) under the DLA's SPE2DB program,...
This federal contract award, with an ID of SPE2DB20D9331|SPE2DB23FL0P9, was issued by the Defense Logistics Agency (DLA) to the prime contractor DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $41,420.70 firm fixed-price delivery order is for the supply of 4559880956 units of the pharmaceutical product KCENTRA 500 UNIT VIALS. The award is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is for the delivery of KCENTRA 500 UNIT VIALS to the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The single-award indefinite delivery contract (IDC) valued at up to $499,999,999 allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 1,000 unit vials of the pharmaceutical product KCENTRA, with a ceiling value of $12,743.68 and a period of performance through May 6, 2025. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical...
This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,729.76, is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain program. The contract covers the procurement of KCENTRA 500UNIT 1S, a pharmaceutical product, with a period of performance through August 30, 2024. The contract has no set-aside designation. This...
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $32,842.92 firm fixed-price delivery order contract is for the supply of 4,558,788,994 units of the drug Kcentra, a blood clotting factor used to treat bleeding disorders. The contract has no set-aside designation and is part of a larger $499,999,999 indefinite delivery contract (IDC)...
This is a delivery order issued by the Defense Logistics Agency (DLA) under the Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $17,297.60 firm fixed-price contract is for the delivery of KCENTRA 500UNIT 1S, a pharmaceutical product, with a completion date of July 12, 2024. The contract is not set-aside and is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS...
This federal contract award, with an ID of SPE2DB20D9331|SPE2DB22FL0W7, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $38,530.70 firm fixed-price delivery order is for the supply of 4557030033 KCENTRA 500 UNIT VIALS, with a completion date of May 12, 2022. The award is associated with a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical...
This federal contract award, with an identified value of $6,797.44, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is a firm fixed-price delivery order under the SPE2DB indefinite delivery contract, which has a ceiling value of up to $499,999,999 and runs through December 31, 2025. This single-award IDC allows the DLA to issue...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $17,297.60 and runs through July 23, 2024. The contract is for the delivery of KCENTRA 500 UNIT VIALS, a blood coagulation factor, to support the recurring medical supply needs of military health facilities. This contract is part of DMS...
  • SPE2DB22D9304
    Indefinite Delivery Contract
  • SPE2DB22D9304-SPE2DB24FSTB5
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,648.80 firm fixed-price delivery order is for the supply of 4,565,783,998 units of the drug KCENTRA 500 with an ultimate completion date of October 2, 2024.

The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This single-award IDC allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation.

Generated 12/11/24, 9:17 AM